About
CardieX develops noninvasive monitoring technologies and digital solutions focused on cardiovascular health. Their products measure central blood pressure at the aorta and arterial stiffness, providing data beyond traditional arm cuff readings. These tools support healthcare providers, researchers, and patients in assessing vascular risk and tracking health progress.
The SphygmoCor technology powers their suite of devices, including wearables like CONNEQT Pulse and Arty, which deliver precise vascular biomarkers. Features cover heart rate variability, cardiac efficiency, and exercise capacity for integrated health insights. This approach enables measured monitoring in clinical settings and at home.
Solutions extend to remote patient monitoring, helping sustain optimized cardiovascular outcomes through connected data.
Longevity Contribution
- Only FDA-cleared noninvasive measurement of central blood pressure and arterial stiffness across all adult demographics.
- SphygmoCor technology as the benchmark for vascular biomarkers, powering cuffless wearables.
- Comprehensive suite of over 15 programmable health features in consumer devices like Arty and CONNEQT Pulse.
- Shift to recurring revenue via subscription-based connected monitoring for population health.